MMR trivalent vaccine based on safety, reactogenicity and immunogenicity observed in 12-24 month-old healthy Filipino children: Evaluation of lot-to-lot consistency of a live-attenuated measles-mumps-rubella
Pediatric Infectious Disease Society of the Philippines Journal
;
: 92-96, 2011.
Article
in English
| WPRIM
| ID: wpr-632366
ABSTRACT
In this double-blind, randomized single-dose study, 194 healthy Filipino children aged 12-24 months were randomized into three groups (111) to receive one of the three lots of live-attenuated measles-mumps-rubella (MMR) vaccine to assess lot-to-lot consistency in safety and immunogenicity. Adverse events were recorded during 43-day post-vaccination follow-up period. Antibody levels were measured using ELISA pre-vaccination and on Day-60. No statistically significant differences were observed across groups for overall incidences of local and general symptoms (p>0.05) or immune response rates against the three antigens (p=0.835, 0.458 and 0.222 for anti-measles, anti-mumps and anti-rubella, respectively). The three lots demonstrated consistency in their reactogenicity and immunogenicity profile.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Enzyme-Linked Immunosorbent Assay
/
Measles-Mumps-Rubella Vaccine
Type of study:
Controlled clinical trial
Limits:
Female
/
Humans
/
Infant
/
Male
Language:
English
Journal:
Pediatric Infectious Disease Society of the Philippines Journal
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS